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Abstract
Background: An 80-year-old woman presented with an abrupt onset of asymptomatic black-to-
purple discoloration of her right limb that appeared just before a thyroid gammagraphy. No
antecedent of trauma was found.
Case presentation: On questioning, patient admitted she did not cooperate during intravenous
administration of Tc-99m-pertechnetate. Based on the abrupt onset of lesions and the absence of
cooperation during intravenous administration of radiotracer, a suspect diagnosis of technetium
and blood extravasation was made. This entity was confirmed in basis of evolution, with a
spontaneous resolution of lesions within the next 15 days with no complications.
Conclusion: Patient and physicians must be reassured because of the non-vesicant property of
technetium. Recovery of this entity is spontaneous, and no treatment is needed.
Case presentation
An 80-year-old woman presented with an abrupt onset of
asymptomatic black-to-purple discoloration of her right
limb that appeared just before a thyroid gammagraphy.
No antecedent of trauma was found. Her medical history
consisted on hypertension, hyperthyroidism and depres-
sion. On questioning, patient admitted she did not coop-
erate during intravenous administration of Tc-99m-
pertechnetate.
Dermatological examination showed an extensive black-
to-purple soft plaque located on her distal right upper
extremity, with a central depressed reddish area that coin-
cided with peripheral intravenous access (Figure. 1). The
remainder of physical examination was within normal
limits. Laboratory evaluation included a complete blood
cell count and a prothrombin and partial thromboplastin
time, all of which were normal.
Based on the abrupt onset of lesions and the absence of
cooperation during intravenous administration of radi-
otracer, a suspect diagnosis of technetium and blood
extravasation was made. This entity was confirmed in
basis of evolution, with a spontaneous resolution of
lesions within the next 15 days with no complications.
Discussion
Soft tissue extravasation of radiotracer and blood after
intravenous administration is a self-limited condition
characterized by the appearance of a purple plaque
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around the area of peripheral intravenous access. It may
result in imaging artefacts [1], so nuclear imaging proce-
dure should be repeated later on.
Recognizing radiotracer and blood extravasation is impor-
tant to avoid misdiagnoses such as skin necrosis or irritant
reactions like those induced by chemotherapy [2], in
which the severity of tissue injury is dependent on the
type and concentration of the chemotherapeutic agent
and the quantity injected. Cytotoxic agents may be classi-
fied as irritants or vesicants. Irritants are drugs that can
cause an inflammatory reaction, aching, swelling, pain or
phlebitis at the injection site or along the vein. Vesicants
are drugs that may cause severe and lasting tissue injury
and necrosis. Symptoms may arise immediately after
extravasation or appear after several days or weeks. In case
of a significant extravasation, necrosis, eschar formation
and ulceration with involvement of underlying tissues
may occur [3].
Patient and physicians must be reassured because of the
non-vesicant property of technetium. Recovery of this
entity is spontaneous, and no treatment is needed.
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Violaceous soft plaque located on the right arm that  appeared after intravenous administration of Tc-99m- pertechnetate Figure 1
Violaceous soft plaque located on the right arm that 
appeared after intravenous administration of Tc-
99m-pertechnetate.